United States · FDA National Drug Code directory
Priftin
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 0088-2102_83c11919-ca6d-49f5-8f9f-7b8405fcbaec
- Product NDC
- 0088-2102
- Form
- TABLET, FILM COATED
- Composition / generic term
- rifapentine
- Labeler
- sanofi-aventis U.S. LLC
- Marketing category
- NDA
- Marketing start / end (source format)
- 20170208
- Source listing expiry
- 20271231
Source-listed ingredients
- RIFAPENTINE — 150 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 3 BLISTER PACK in 1 CARTON (0088-2102-24) / 8 TABLET, FILM COATED in 1 BLISTER PACK (0088-2102-01) · 0088-2102-24
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →